NASDAQ · LSB
Healthcare · Biotechnology
$0.63
Up+$0.00 (+0.00%)
Updated Aug 22, 2026, 3:21 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
LSB does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning LSB.
LSB research
Company profile and research snapshot.
LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. LakeShore Biopharma Co., Ltd was founded in 2002 and is based in Beijing, China.
Visit company websiteConsensus and target data currently published for this company.
No generated briefing is available yet.
Finnhub · Apr 29, 2026
EQS-News: LAKESHORE BIOPHARMA CO., LTD / Key word: FinancialLakeShore Biopharma Enters Into Amended Merger Agreement for Going-Private Transaction 29.04.2026 / 14:03 CET/CESTThe issuer is...
businesswire.com · Nov 13, 2025
OKLAHOMA CITY--(BUSINESS WIRE)--LSB Industries, Inc. (“LSB”), (NYSE: LXU), today announced that its Executive Vice President and Chief Financial Officer, Cheryl Maguire will be participating in the NYSE Industrials Virtual Conference on November 18th and 19th. Ms. Maguire will be available for one-on-one meetings all day on November 19th. To schedule a meeting please contact the NYSE via email at [email protected]. About LSB Industries, Inc. LSB Industries, Inc., headquartered in Oklahom.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning LSB.
No results
No recent SID articles mention LSB.
